Detection of Biallelic Loss of DNA Repair Genes in Formalin-Fixed, Paraffin-Embedded Tumor Samples Using a Novel Tumor-Only Sequencing Panel

Dominik Głodzik(Memorial Sloan Kettering Cancer Center), Jorge S. Reis‐Filho(AstraZeneca (France)), Pier Selenica(Memorial Sloan Kettering Cancer Center), Nirav Malani(Invitae (United States)), Robert Daber(University of Pennsylvania), Nadeem Riaz(Memorial Sloan Kettering Cancer Center), Ian M. Silverman(Xilio Therapeutics (United States)), Ryan Rogge(Invitae (United States)), Michael Zinda(Io Therapeutics (United States)), María Koehler(Pfizer (United States)), Diana Mandelker(Memorial Sloan Kettering Cancer Center), Victoria Rimkunas, Sam Harris(UK Dementia Research Institute), Artur Veloso(Universidade Federal de Minas Gerais), Verity Johnson(University of Colorado Boulder), Jianhua Zhao(Southwest Petroleum University)
Journal of Molecular Diagnostics
March 20, 2023
10.1016/j.jmoldx.2023.02.004
Cited by 7

Related Papers

The Consensus Coding Sequences of Human Breast and Colorectal Cancers
|Science|2006|3.2k
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
|The Lancet Oncology|2016|1.8k
Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
|New England Journal of Medicine|2015|1.6k
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
|Nature|2017|1.2k
<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
|New England Journal of Medicine|2012|1k